business

GNI Group to acquire Ayumi Pharmaceutical for ¥44.8 billion

Investing.com · Jun 7, 2026, 11:45 PM · Also reported by 1 other source

Read full story on Investing.com → More top stories

Also covered by

Bloomberg Markets Ingredion Is in Advanced Talks to Acquire Tate & Lyle for £2.7 billion

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

GNI Group to acquire Ayumi Pharmaceutical for ¥44.8 billion

Also covered by

More in business